MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, RNAC has $296,411K in assets. $422,651K in debts. $125,139K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
865.47%
Quick Ratio
865.47%
Cash Ratio
837.78%
Debt to Asset Ratio
142.59%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • In-process research and developm...
    • Goodwill
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Contingent value right liability...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
125,139
Accounts receivable
1,115
Prepaid expenses and other current assets
3,022
Total current assets
129,276
Property and equipment, net
12,185
Right-of-use assets, net
5,601
In-process research and development assets
93,900
Goodwill
48,163
Long-term restricted cash
1,735
Investment
0
Long-term prepaid expenses and other assets
5,551
Total assets
296,411
Accounts payable
1,288
Accrued expenses and other current liabilities
9,498
Lease liabilities
4,151
Contingent value right liability
0
Total current liabilities
14,937
Lease liabilities, net of current portion
8,525
Warrant liability
141
Contingent value right liability, net of current portion
392,100
Deferred tax liabilities, net
6,948
Total liabilities
422,651
Preferred stock, value, issued-Series APreferred Stock
0
Preferred stock, value, issued-Series BPreferred Stock
0
Preferred stock, value, issued
0
Common stock, 0.0001 par value 350,000,000 shares authorized as of december 31, 2025 and 2024 26,011,106 and 25,767,369 shares issued and outstanding as of december 31, 2025 and 2024, respectively
3
Additional paid-in capital
700,706
Accumulated deficit
-822,373
Accumulated other comprehensive loss
-4,576
Total stockholders deficit
-126,240
Total liabilities and stockholders deficit
296,411
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$125,139K Prepaid expenses andother current assets$3,022K Accounts receivable$1,115K Total current assets$129,276K In-process research anddevelopment assets$93,900K Goodwill$48,163K Property and equipment,net$12,185K Right-of-use assets, net$5,601K Long-term prepaidexpenses and other assets$5,551K Long-term restricted cash$1,735K Total assets$296,411K Accumulated deficit-$822,373K Accumulated othercomprehensive loss-$4,576K Total liabilities andstockholders deficit$296,411K Total stockholdersdeficit-$126,240K Additional paid-in capital$700,706K Common stock, 0.0001par value...$3K Total liabilities$422,651K Contingent value rightliability, net of current...$392,100K Total currentliabilities$14,937K Lease liabilities,net of current...$8,525K Deferred taxliabilities, net$6,948K Warrant liability$141K Accrued expenses andother current...$9,498K Lease liabilities$4,151K Accounts payable$1,288K

Cartesian Therapeutics, Inc. (RNAC)

Cartesian Therapeutics, Inc. (RNAC)